Amolyt Pharma - Ownership and Business Overview

Life ScienceCompany

Amolyt Pharma Ownership

Who owns Amolyt Pharma?

Amolyt Pharma is owned by AstraZeneca. It was acquired on March 14, 2024.

Was Amolyt Pharma formerly PE-backed?

Yes. Amolyt Pharma was formerly owned by 2 private investors.

Amolyt Pharma Business Overview

Where is Amolyt Pharma headquartered?

Amolyt Pharma is headquartered in Ecully, France.

What sector is Amolyt Pharma in?

Amolyt Pharma is a life science company.

When was Amolyt Pharma founded?

Amolyt Pharma was founded in 2015.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 184 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 170 by strategics.

Amolyt Pharma

Amolyt Pharma SAS

15, chemin du Saquin Espace Europeen, Building G,
Ecully, 69 130
France,
+33 428 01 21 54
www.amolytpharma.com

Amolyt Pharma is a clinical-stage biotechnology company, building therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma was founded in 2015 and is based in Ecully, France.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Amolyt Pharma

Life Science Companies , France Companies